• Small Molecules
      • Discovery
    • Large Molecules
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers

Small Molecules

Syngene is a full-scale Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) with extensive experience.

Discovery

Our small molecules Discovery Services span the entire spectrum of early-stage research from target identification to delivery of drug candidates for further development. Our services cover Chemistry, Biology, Safety Assessment & Toxicology, and Research Informatics. Additionally, we also support integrated drug discovery for small molecules with SynVent – Syngene’s platform for fully integrated therapeutic discovery and development.
Discovery Chemistry
Discovery Biology
Safety Assessment
Research Informatics
SynVantage  

Development

Syngene offers preclinical development, API and drug product development. We offer drug development services from lead generation to clinical supplies of drug substance and drug product. Our Clinical development services are across Phase I, II & III trials. We also support our clients in drug filing with FDA and other global regulatory authorities.

What sets our Development services apart, is our full-service capability and well-rounded expertise to enable seamless integration of R&D programs, resulting in faster go-to-market opportunity for our clients.

Chemical Development
Formulation Development
Analytical Development
Clinical Development

Manufacturing

Syngene has capabilities for current Good Manufacturing Practices (cGMP) manufacturing from benchtop volume to commercial scale. Since 2015, we have generated around 150 metric tons of materials for various projects. We offer end-to-end solutions from GLP-Tox batches to clinical supplies, scale up, launch and commercial manufacturing.

Commercial Manufacturing

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements.

To find out more, read our Privacy Policy and Cookies Policy.

To download, Please share your details

To download, Please share your details